DUBLIN--(BUSINESS WIRE)--May 26, 2015--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the Jefferies 2015 Global Healthcare Conference
on Monday, June 1, 2015, at 11:30 a.m. EDT (4:30 p.m. BST) from the
Grand Hyatt New York. The presentation may be accessed under the
Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
developing innovative medicines for the treatment of central nervous
system (CNS) diseases. The company has a diversified commercial product
portfolio and a substantial clinical pipeline of product candidates for
chronic diseases that include schizophrenia, depression, addiction and
multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has
an R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more information, please visit Alkermes’ website
at www.alkermes.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150526005991/en/
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1 781 609 6823
Corporate
Communications
